ir.aptose.com ir.aptose.com

ir.aptose.com

Aptose Biosciences - Investors - Overview

SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.

http://ir.aptose.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.APTOSE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 14 reviews
5 star
4
4 star
6
3 star
4
2 star
0
1 star
0

Hey there! Start your review of ir.aptose.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1 seconds

FAVICON PREVIEW

  • ir.aptose.com

    16x16

CONTACTS AT IR.APTOSE.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Aptose Biosciences - Investors - Overview | ir.aptose.com Reviews
<META>
DESCRIPTION
SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.
<META>
KEYWORDS
1 overview
2 our story
3 management team
4 board of directors
5 scientific advisory board
6 product pipeline
7 technology and indications
8 other heme malignancies
9 epigenetic program
10 investors
CONTENT
Page content here
KEYWORDS ON
PAGE
overview,our story,management team,board of directors,scientific advisory board,product pipeline,technology and indications,other heme malignancies,epigenetic program,investors,press releases,events and presentations,stock information,corporate governance
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Aptose Biosciences - Investors - Overview | ir.aptose.com Reviews

https://ir.aptose.com

SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.

INTERNAL PAGES

ir.aptose.com ir.aptose.com
1

Process Calendar

http://ir.aptose.com/ProcessCalendarRequest.asp?eventId=5245946&OverridePage=irol-EventDetails&checkJS=false

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

OTHER SITES

ir.applied.com ir.applied.com

Investor Relations Home | Applied Industrial Technologies | Applied.com

Applied Industrial Technologies is a leading North American distributor of industrial products and services. Why Invest in Applied? E-mail the Board of Directors. Q4 2015 Applied Industrial Technologies Earnings Conference Call. 160;at 10:00 am ET. Q4 2015 Applied Industrial Technologies Earnings Conference Call. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. 160; 0.23. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. CLEVELAND, ...

ir.approachresources.com ir.approachresources.com

Approach Resources - Investors

Approach Resources Inc. (NASDAQ: AREX) is an independent oil and gas company headquartered in Fort Worth, Texas. Our operations are focused on exploration, development, production and acquisition of oil and gas properties. We own a leading position in the southern Midland Basin of the greater Permian Basin in West Texas, where we are developing the horizontal Wolfcamp shale oil play. Approach Resources Inc. Reports Second Quarter 2015 Results. View All News Releases. Abundant, Low-cost drilling targets.

ir.apricusbio.com ir.apricusbio.com

Investor Home | Investors | Apricus Biosciences

Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...

ir.aptevotherapeutics.com ir.aptevotherapeutics.com

Investor Home : Investors : Aptevo

Aptevo Therapeutics and the ADAPTIR (Modular Protein Technology) Platform: The Future of Immuno-oncology. 160;  0.08 (3.21%). Updated January 13, 2017  4:00 pm ET. Stacey L. Jurchison. Senior Director, Investor Relations and Corporate Communications. Aptevo Therapeutics Inc at 29th Annual ROTH Conference. Aptevo Therapeutics Inc at the 16th Annual PEPTALK Conference. Aptevo Therapeutics Inc at Piper Jaffray 28th Annual Healthcare Conference.

ir.aptg.com.tw ir.aptg.com.tw

A+ Asia Pacific Telecom Website

ir.aptose.com ir.aptose.com

Aptose Biosciences - Investors - Overview

SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.

ir.aqr.com ir.aqr.com

AQR Capital - Investor Relations - Overview

Investor and Media Contact. There are currently no news releases. Primary IR and Media Contact. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Powered and implemented by Interactive Data Managed Solutions.

ir.aquaamerica.com ir.aquaamerica.com

Investor Relations | Aqua America

Skip to main navigation. Reconciliation of GAAP to Non-GAAP Financial Measures. Regulated segment - Efficiency ratio adjusted for purchased water. Reconciliation of GAAP to Non-GAAP financial measures - EBITDA reconciliation for continuing operations. Adjusted Net Income EPS Q4 2017. Dividend Reinvestment and DSPP. There are currently no events to display. Feb 27, 2018. Aqua America Reports Earnings for 2017, Announces 2018 Guidance. Feb 5, 2018. Aqua America Declares March 2018 Dividend. Feb 1, 2018.

ir.arafaholding.com ir.arafaholding.com

Arafa Holding | Investor Relations

Board and Shareholders Actions. Share and Corporate Information. Luxury, Formal and Casual Wear across own brands. Textiles, Apparel and Tailoring, Retail and Distribution. Concrete, with 47 retail stores nationwide across Egypt. Learn about Arafa Holding's business model, strategy, brands and partnerships through our downloadable presentations in the Presentations and Publications center. As of 16:02, on Thu, Aug, 13 2015. Arafa Earnings Release 1Q2015. Arafa Holding Financials 1Q2015 (Arabic).

ir.arcadis.com ir.arcadis.com

Arcadis Investors - ARCADIS NV - Investor Relations

United Kingdom (ARCADIS AYH). ARCADIS at a Glance. Reasons to invest in ARCADIS. Share Quote and Chart. Risk and Risk Management. IR Team and Subscriptions. To opt-in to receive our quarterly retail investor newsletter. ARCADIS Q2 2015 Results. Jul 29, 2015 at 3:00 PM CET. Tetra Tech, Inc. 07 Aug 2015 latest: 17:35 CET. Euro; 22.38. Amounts in € millions unless otherwise stated. Organic gross revenue growth. Organic net revenue growth. Net income per share (in €). Net income from operations.

ir.archcapgroup.com ir.archcapgroup.com

Arch > Investor Information

Earnings Releases and Supplements. Non-US. Subsidiary Information. 07/30/2015 11:00 AM ET. Q2 2015 Arch Capital Group Earnings Conference Call. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Arch Capital Group Earnings Conference Call. Thursday, July 30, 2015. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. Maintain a disciplined underwriting approach to enable us to se...